跳至主要内容
临床试验/DRKS00026832
DRKS00026832已完成未知

Embryo transfer with intrauterine application of human chorionic gonadotropin (hCG) to improve implantation- and pregnancy rates - a randomized controlled study

IVF-Zentren Prof. Zech, Pilsen0 个研究点目标入组 1,252 人开始时间: 2021年10月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,252

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 43 Years(—)
性别
All

入选标准

  • Included were all fresh blastocyst transfers on day 5 after ovum pick up

排除标准

  • Female age =44 years (no age limit for male partner)
  • Known chromosomal aberration either by female or by male partner
  • IVF-cycles with preimplantation genetic analysis
  • IVF-cycles with use of donor oocytes
  • Patients with recurrent implantation failure (=3 negative IVF-cycles)

研究者

发起方
IVF-Zentren Prof. Zech, Pilsen

相似试验

Embryo transfer with intrauterine application of... | 临床试验